The PennZone

  • Home
  • Business
  • Real Estate
  • Travel
  • Health
  • Technology
  • Non-profit
  • Construction
  • Legal

New Book Further Unravels the Myth of a "Chemical Imbalance" Causing Depression
The PennZone/10293893

Trending...
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Don't Get Burned by High Heater Prices in Philly This Winter!
Chemically Imbalanced
Professor Joanna Moncrieff's new book Chemically Imbalanced has prompted the Citizens Commission on Human Rights to call for greater treatment consent provisions to inform patients a "chemical imbalance" in the brain causing depression is disproved.

LOS ANGELES - PennZone -- Described as authoritative and well-researched, a new book by Professor Joanna Moncrieff, Chemically Imbalanced: The Making and Unmaking of the Serotonin Myth,[1] has reinforced calls from the mental health industry watchdog Citizens Commission on Human Rights (CCHR) International calls for patients to be fully informed that a chemical imbalance in their brain is not the source of their emotional issues.

Moncrieff, a professor of psychiatry at University College London, earlier led a systematic review of meta-studies examining the relationship between the chemical serotonin and depression. Alongside a team of five leading UK and European specialists, she concluded from all relevant published studies that "there is no evidence of a connection between reduced serotonin levels of activity and depression." Published in Molecular Psychiatry in 2022, the study was read by over one million people, "attracted international coverage," and sent "shockwaves through academic psychiatry."[2]

The study is now one of the most widely read and influential scientific papers of modern times. Altmetric, an online influence tracker, ranks it in the top five percent of all papers.[3]

In discussing her new book, Prof. Moncrieff wrote, "The fact is the theory that depression is caused by low serotonin is not supported by reliable evidence. Put simply, the emperor has no clothes – and this matters, because our widespread use of antidepressants for mental health problems is grounded in this myth."

She further explains, "Indeed, all mental health problems – as they're now referred to – are overwhelmingly seen as medical conditions arising from a chemical imbalance, or something similar, which needs correcting with drugs just like other diseases."[4]

This misconception has contributed to the widespread use of antidepressants. IQVia, the largest vendor of U.S. physician prescribing data, reports that 45 million Americans are taking antidepressants, including 2.1 million children aged 0-17.[5]

More on The PennZone
  • Tri-State Area Entrepreneur Launches K-Chris: A Premium Digital Destination for Luxury Fragrances
  • Why One American Manufacturer Builds BBQ Smokers to Aerospace Standards
  • Diversified Roofing Solutions Strengthens Industry Leadership With Expanded Roofing Services Across South Florida
  • ZRCalc™ Cinema Card Calculator Now Available for Nikon ZR Shooters
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy

"My view on depression is that it's a complex emotional state usually arising from life difficulties, rather than a biologically determined condition," Prof. Moncrieff adds. She emphasizes the importance of ensuring people are "properly informed about what they take," noting that this was her aim when publishing the comprehensive 2022 overview of research into depression and serotonin.[6]

According to Psychology Today's review on Chemically Imbalanced, the serotonin hypothesis served as "the principal justification for the use of antidepressants." The review states, "Moncrieff shows how the framing of depression and its treatment evolved from a 'drug-centered' to a 'disease-centered' model, with significant implications for how we think about the condition, even before we set about treating it."[7] The book contends that "the process of medicalization only makes things worse. It gives people false hope and leads to the over-prescription of potentially harmful drugs that, at best, offer ways to stifle uncomfortable feelings. We have to find better ways to help people."

Prof. Moncrieff suggests that better approaches to treatment would be "first and foremost about helping people to address the problems in their lives."[8]

This perspective is further underscored by data showing that 8.6 million people in England—nearly 19% of adults—were taking an antidepressant in 2022-23.[9] This is despite the 2019 position statement from the Royal College of Psychiatrists in the UK, which also found no evidence linking low serotonin levels to causing depression and dismissed the notion that antidepressants "correct a chemical imbalance in the brain."[10]

Yet, "at the same time, the quest for money and professional status has lured the psychiatric profession (whether individuals are consciously aware of it or not) into promoting these barely useful and potentially harmful drugs," Prof. Moncrieff says. "People have been profoundly misled about antidepressants." She details: "Not only have they never been shown to rectify a chemical imbalance or any other abnormality, but…they actually interfere with the normal state of the brain, just like alcohol and other mind-altering drugs. This is how they can produce potentially devastating side-effects – from rare suicidal thoughts to severe sexual problems."[11]

She adds: "Prescribing drugs has also long fulfilled the ambitions of the psychiatric profession to be just like other doctors – bringing them 'out of the asylum' by administering pills to make patients better."[12]

More on The PennZone
  • $36 Million LOI to Acquire High Value Assets from Vivakor Inc in Oklahoma's STACK Play — Building Cash Flow and Scalable Power Infrastructure; $OLOX
  • Kobie Wins for AI Innovations in the 2026 Stevie® Awards for Sales & Customer Service
  • Author Jeff Bogle to Host Street Cats Mediterranean Cruise Featuring Cat Behaviorist Molly DeVoss
  • Berman | Sobin | Gross LLP Celebrates 35 Years of Advocating for Maryland's Injured Workers and Families
  • Art of Whiskey Hosts 3rd Annual San Francisco Tasting Experience During Super Bowl Week

However, CCHR argues that these pills have failed to improve the overall mental health of U.S. or UK citizens. Instead, the number of people taking them is increasing, not decreasing.

CCHR says that the chemical imbalance information must translate into stronger informed consent procedures within the mental health system. CCHR, which was established in 1969 by the Church of Scientology and Professor of psychiatry, Thomas Szasz, has been raising awareness about the lack of scientific evidence supporting the chemical imbalance theory of mental disorders. It has provided a detailed timeline of this issue on its website and has consistently fought for greater informed consent rights for patients.

CCHR calls for doctors to ensure that mental health patients are disabused of the idea that a chemical imbalance is what ails them as the first step in this informed consent process.

Sources:

[1] "'Chemically Imbalanced': A Book Review, A new history of antidepressants challenges the evidence supporting their use," Psychology Today, 16 Jan 2025, www.psychologytoday.com/us/blog/side-effects/202501/chemically-imbalanced-a-book-review

[2] "'Chemically Imbalanced': A Book Review…" Psychology Today, 16 Jan 2025

[3] "Medicating misery by doling out antidepressants is based on a myth: NHS psychiatrist PROFESSOR JOANNA MONCRIEFF reveals the shameful truth about Big Pharma," Daily Mail, 13 Jan. 2025, www.dailymail.co.uk/health/article-14279653/Medicating-misery-antidepressants-myth-NHS-psychiatrist-PROFESSOR-JOANNA-MONCRIEFF.html

[4] "Medicating misery by doling out antidepressants is based on a myth…," Daily Mail, 13 Jan. 2025

[5] www.cchrint.org/psychiatric-drugs/people-taking-psychiatric-drugs/; www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/

[6] "Medicating misery by doling out antidepressants is based on a myth…," Daily Mail, 13 Jan. 2025

[7] "'Chemically Imbalanced': A Book Review…" Psychology Today, 16 Jan 2025

[8] "'Chemically Imbalanced': A Book Review…" Psychology Today, 16 Jan 2025

[9] "Medicating misery by doling out antidepressants is based on a myth…," Daily Mail, 13 Jan. 2025

[10] www.cchrint.org/2022/08/09/world-psychiatric-group-must-tell-its-members-to-expunge-chemical-imbalance-myth/ citing: Royal College of Psychiatrists, "Position statement on antidepressants and depression," May 2019

[11] "Medicating misery by doling out antidepressants is based on a myth…," Daily Mail, 13 Jan. 2025

[12] "Medicating misery by doling out antidepressants is based on a myth…," Daily Mail, 13 Jan. 2025

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Brain Drain Unlimited Strengthens Legal Advocacy with Advanced Training from Villanova University
  • Don't Settle for a Lawyer Who Just Speaks Spanish. Demand One Who Understands Your Story
  • Dan Williams Promoted to Century Fasteners Corp. – General Manager, Operations
  • Ski Johnson Inks Strategic Deals with Three Major Food Chain Brands
  • NIL Club Advances Agent-Free NIL Model as Oversight Intensifies Across College Athletics
  • Pallet Company Partners with Internet Marketing Company
  • Atlanta Magazine Names Dr. Rashad Richey One of Atlanta's Most Influential Leaders in 2026 as the FIFA World Cup Approaches
  • Apostle Margelee Hylton Announces the Release of Third Day Prayer
  • Slotozilla Reports Strong Q4 Growth and Sigma Rome Success
  • "Lights Off" and Laughs On: Joseph Neibich Twists Horror Tropes in Hilariously Demonic Fashion
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Beethoven: Music of Revolution and Triumph - Eroica
  • Don't Get Burned by High Heater Prices in Philly This Winter!
  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
  • Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
  • Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season
  • Still Using Ice? FrostSkin Reinvents Hydration

Popular on PennZone

  • Michael Judkins Releases New Poetry Book, Deeper Than You Think
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Accountants Near Me Cheyenne Opens U.S. Directory for Accountants, Bookkeepers and Tax Services
  • NOW OPEN - New Single Family Home Community in Manalapan
  • Precision Adult Care Expands 24/7 Adult In-Home Care Services to Meet Growing Demand in the Coachella Valley
  • Boston Industrial Solutions' Natron® 512N Series UV LED Ink Earns CPSIA Certification
  • Why 'Instant-Liquidity' Gaming is Dominating the Nordic Tech Demographic
  • 2025 Top Lawyers - ELA Awards by Expert Law Attorneys
  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors

Similar on PennZone

  • Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
  • When Representation No Longer Reflects the District — Why I'm Voting for Pete Verbica
  • Why One American Manufacturer Builds BBQ Smokers to Aerospace Standards
  • Revolutionary Data Solution Transforms Health Insurance Underwriting Accuracy
  • Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
  • Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us